Omega Therapeutics (OMGA) Competitor Comparison
We are evaluating the key criteria listed to compare Omega Therapeutics (OMGA) against its competitors in the Biotechnology industry.
Market Capitalization
217 / 368Gross Profits
217 / 278Total Revenue
217 / 300EBITDA
215 / 337Free Cashflow
235 / 352Quick Ratio
247 / 357Earnings per Share
161 / 359Dividend yield
0 / 6Total Cash
223 / 358Performance 3 years
335 / 368Performance 5 years
324 / 368Performance 10 years
293 / 368Linearity 3 years
271 / 368Linearity 5 years
245 / 368Linearity 10 years
209 / 368Total Rank
215 / 368Dividend Rank
226 / 368Valuation Rank
116 / 368Piotroski Rank
299 / 368Muliplier Rank
169 / 368Total Cash - OMGA ranking 223 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.